Avelox is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Redpharm Drug Inc.. The primary component is Moxifloxacin Hydrochloride.
| Product ID | 67296-0154_4c8fe3c9-0537-4fda-aef5-918f0a961a8b |
| NDC | 67296-0154 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Avelox |
| Generic Name | Moxifloxacin Hydrochloride |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-02-25 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021085 |
| Labeler Name | RedPharm Drug Inc. |
| Substance Name | MOXIFLOXACIN HYDROCHLORIDE |
| Active Ingredient Strength | 400 mg/1 |
| Pharm Classes | Quinolone Antimicrobial [EPC],Quinolones [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2011-02-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021085 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-02-25 |
| Inactivation Date | 2019-10-29 |
| Marketing Category | NDA |
| Application Number | NDA021085 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-02-25 |
| Inactivation Date | 2019-10-29 |
| Marketing Category | NDA |
| Application Number | NDA021085 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-02-25 |
| Inactivation Date | 2019-10-29 |
| Ingredient | Strength |
|---|---|
| MOXIFLOXACIN HYDROCHLORIDE | 400 mg/1 |
| SPL SET ID: | fe9226f8-64f4-4eff-8339-ed3fce0896f2 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0085-1733 | Avelox | moxifloxacin hydrochloride |
| 0085-1737 | Avelox | moxifloxacin hydrochloride |
| 50419-530 | Avelox | Avelox |
| 50419-537 | Avelox | Avelox |
| 67296-0154 | Avelox | Avelox |
| 0065-0006 | MOXEZA | moxifloxacin hydrochloride |
| 48792-7823 | Moxifloxacin | moxifloxacin hydrochloride |
| 0093-7387 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
| 0832-1410 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
| 13668-201 | moxifloxacin hydrochloride | moxifloxacin hydrochloride |
| 40032-034 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
| 43063-580 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride |
| 43063-585 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride |
| 47781-268 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride |
| 50090-4058 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
| 50090-4100 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
| 0781-7135 | Moxifloxacin Ophthalmic Solution | moxifloxacin hydrochloride |
| 0065-4013 | VIGAMOX | moxifloxacin hydrochloride |
| 0078-0939 | VIGAMOX | moxifloxacin hydrochloride |
| 21695-968 | VIGAMOX | moxifloxacin hydrochloride |
| 50090-0859 | VIGAMOX | moxifloxacin hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AVELOX 78092603 2780658 Live/Registered |
Bayer Aktiengesellschaft 2001-11-09 |
![]() AVELOX 75400008 2373382 Live/Registered |
Bayer Aktiengesellschaft 1997-12-04 |